Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-11-17

FDA Approved: TELMISARTAN AND AMLODIPINE — Original Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

FDA approved Alembic Pharmaceuticals Limited's original application for a generic fixed-dose combination tablet of telmisartan and amlodipine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Telmisartan and Amlodipine (Telmisartan and Amlodipine)

Snippet

ORIG AP for TELMISARTAN AND AMLODIPINE (TELMISARTAN AND AMLODIPINE)